Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zentek Ltd (TSV: ZEN )

1.500 +0.040 (+2.74%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,127
Open 1.440
Bid (Size) 1.440 (15)
Ask (Size) 1.520 (31)
Prev. Close 1.460
Today's Range 1.440 - 1.500
52wk Range 1.300 - 2.300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto
Via ACCESSWIRE
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
Via ACCESSWIRE

Performance

YTD
-12.79%
-12.79%
1 Month
-0.66%
-0.66%
3 Month
-18.92%
-18.92%
6 Month
-13.29%
-13.29%
1 Year
-25.37%
-25.37%

More News

Read More
Zentek Announces Board and Management Changes
Via ACCESSWIRE
Zentek Provides ZenGUARD(TM) Business Update
Via ACCESSWIRE
Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions
Via ACCESSWIRE
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
Via ACCESSWIRE
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
Via ACCESSWIRE
Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
Via ACCESSWIRE
Zentek Announces Eric Wallman Appointed as Chairman of the Board
Via ACCESSWIRE
Zentek Launches Triera Biosciences Ltd.
Via ACCESSWIRE
Zentek and 1Click Heating and Cooling Sign Distribution Agreement
Via ACCESSWIRE
Zentek Announces Grant of Stock Options
Via ACCESSWIRE
Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
Via ACCESSWIRE
Zentek Announces Update on the Albany Graphite Project
Via ACCESSWIRE
Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology
Via ACCESSWIRE
Zentek Completes Return on Investment Analysis for Canadian Healthcare System
Via ACCESSWIRE
Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose
Via ACCESSWIRE
Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology
Via ACCESSWIRE
Zentek Provides Corporate Update
Via ACCESSWIRE
Global Nanocoatings Market Projected To Reach $39 Billion By 2028 Fueling Additional Research & Development Activities
Via FinancialNewsMedia
Topics Stocks
Exposures US Equities
Zentek to Showcase ZenGUARD(TM) for HVAC at BUILDEX Alberta 2023
Via ACCESSWIRE
Zentek Announces Annual General Meeting on Thursday October 5th, 2023, at the Delta Hotel in Guelph, Ontario
Via ACCESSWIRE
Zentek’s ZenGUARD(TM)-Enhanced Filters Demonstrate Robust Return on Investment in ParticleOne Study
Via ACCESSWIRE
Zentek Announces Breakthrough Results in Viral Filtration Efficiency with Dust Loading
Via ACCESSWIRE
Zentek Announces Distribution and Supply Agreement with Henry Schein, Inc.
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.